Energenesis Biomedical Co (TPE:6657) Cash Flow for Lease Financing : NT$-6.13 Mil (TTM As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Energenesis Biomedical Co Cash Flow for Lease Financing?

Energenesis Biomedical Co's Cash Flow for Lease Financing for the three months ended in Mar. 2025 was NT$-1.49 Mil. Energenesis Biomedical Co's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2025 was NT$-6.13 Mil.

Compared with last quarter (NT$-1.50 Mil in Dec. 2024 ), Energenesis Biomedical Co's Cash Flow for Lease Financing increased in Mar. 2025 (NT$-1.49 Mil).

Energenesis Biomedical Co Cash Flow for Lease Financing Historical Data

The historical data trend for Energenesis Biomedical Co's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Energenesis Biomedical Co Cash Flow for Lease Financing Chart

Energenesis Biomedical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash Flow for Lease Financing

Get a 7-Day Free Trial

-4.23

-6.79

-6.51

-6.52

-6.20

Energenesis Biomedical Co Quarterly Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Cash Flow for Lease Financing	Get a 7-Day Free Trial															-1.56	-1.57	-1.58	-1.50	-1.49

Energenesis Biomedical Co Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.

Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-6.13 Mil.

Energenesis Biomedical Co Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Energenesis Biomedical Co's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Energenesis Biomedical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Energenesis Biomedical Co Ltd (TPE:6657) » Definitions » Cash Flow for Lease Financing

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 21, Lane 583, Ruiguang Road, 6th Floor -3, Neihu District, Taipei, TWN, 11492

Website

https://www.energenesis-biomedical.com

Energenesis Biomedical Co Ltd is a biomedicine company. It is engaged in businesses related to biological experimentation and analysis, as well as new drug development. The company uses its ENERGI drug development platform to activate AMP-activated protein kinase (AMPK), a key enzyme in cell energy regulation, as a means of developing disease treatments. Its product pipeline consists of ENERGI-F703, a diabetic foot ulcers treatment gel; ENERGI-F701, a product developed for male hair loss; ENERGI-F704, an inflammatory bowel disease treatment; and ENERGI-F711, a burn cream, among others.

Energenesis Biomedical Co Headlines

No Headlines